{"hands_on_practices": [{"introduction": "A classic strategy to uncover the primary function of a cellular component is to observe the consequences of its removal. This exercise asks you to perform a thought experiment based on this principle. By predicting the most likely outcome of depleting a core structural subunit of the Mediator complex, you can deduce its most critical, overarching role in the cell's transcriptional machinery. [@problem_id:2342599]", "problem": "In a eukaryotic cell culture experiment, a researcher aims to investigate the function of the Mediator complex, a large multi-protein assembly crucial for gene expression. The researcher employs RNA interference (RNAi), a technique that specifically degrades the messenger RNA (mRNA) for a target protein, to significantly deplete the levels of a single protein subunit that is essential for the structural integrity of the entire Mediator complex. Assuming the RNAi treatment is highly effective and specific, what is the most likely, broad consequence on the process of transcription by RNA Polymerase II within these cells?\n\nA. The process of transcript elongation by RNA Polymerase II will be prematurely terminated for all actively transcribed genes.\n\nB. The general transcription factors (e.g., TFIIB, TFIID) will be unable to bind to any core promoter sequences across the genome.\n\nC. The communication between gene-specific activator proteins bound to enhancer regions and the general transcription machinery at the promoter will be severely impaired.\n\nD. The enzymatic activity of RNA Polymerase II, specifically its ability to add ribonucleotides, will be directly inhibited.\n\nE. All transcription will be completely halted, as the Mediator complex is strictly required for the initiation of transcription for every gene.", "solution": "The Mediator complex is a multi-subunit coactivator that physically bridges gene-specific transcription activators bound at enhancers to the general transcription machinery, including RNA Polymerase II and the general transcription factors, at core promoters. Its core function is to facilitate communication and productive assembly and regulation of the pre-initiation complex, integrating regulatory signals to modulate transcription initiation and, in some contexts, early promoter escape and pause release.\n\nIf RNA interference is used to deplete a single protein subunit that is essential for the structural integrity of the entire Mediator complex, the functional Mediator assembly will be largely disrupted. This disruption would impair the ability of enhancer-bound activators to influence the Pol II pre-initiation complex at promoters, because the primary bridging and regulatory conduit is compromised.\n\nThis consequence does not imply that the enzymatic activity of RNA Polymerase II is directly inhibited, because Mediator is not a catalytic inhibitor of Pol II (contradicting option D). It also does not imply that general transcription factors such as TFIID and TFIIB are globally unable to bind core promoters; these factors can recognize promoter elements and assemble basal machinery independently of Mediator, although Mediator enhances and stabilizes activated transcription (contradicting option B). Nor does Mediator loss cause universal premature elongation termination across all genes (contradicting option A), as Mediator’s principal role is in initiation and regulatory communication rather than serving as an elongation termination factor. Finally, while Mediator is broadly important for regulated transcription and many genes depend on it, it is not strictly required for all transcription at every gene under all conditions; some basal transcription can persist without a fully intact Mediator (contradicting the absolute claim in option E).\n\nTherefore, the most likely broad consequence is that communication between enhancer-bound activators and the general transcription machinery at promoters is severely impaired, which best matches option C.", "answer": "$$\\boxed{C}$$", "id": "2342599"}, {"introduction": "The Mediator complex is not a simple, monolithic entity; its power lies in its modular architecture, which allows for both broad and highly specific gene regulation. This problem challenges you to think critically about this structure-function relationship. By comparing the hypothetical effects of disrupting a core \"Head\" module subunit versus a pathway-specific \"Tail\" module subunit, you can appreciate how Mediator integrates global and targeted transcriptional control. [@problem_id:2342580]", "problem": "In eukaryotic cells, the Mediator complex is a large, multi-subunit protein assembly that functions as a critical coactivator for transcription by RNA Polymerase II. Its structure is modular, consisting of a \"core\" (composed of Head and Middle modules) and peripherally associated \"variable\" modules (the Tail and Kinase modules). The core Mediator, particularly the Head module, is responsible for physically bridging transcription factors to the general transcription machinery at the promoter, a function required for the expression of most protein-coding genes. In contrast, the Tail module subunits function to recognize and bind to specific transcription factors, thereby recruiting Mediator to a particular subset of genes involved in distinct developmental or signaling pathways.\n\nConsider two genetically engineered diploid cell lines, derived from a common wild-type parent, cultured under identical standard conditions.\n\n- **Cell Line A:** This line is heterozygous for a null allele of a gene encoding a subunit of the Head module. The protein product of this gene is indispensable for the stable association of the Mediator complex with RNA Polymerase II.\n- **Cell Line B:** This line is heterozygous for a null allele of a gene encoding a subunit of the Tail module. This specific subunit is known to be required exclusively for the transcriptional activation of genes responsive to a single, non-essential nutrient-sensing pathway.\n\nBased on this information, which of the following statements most accurately predicts the comparative global impact on the transcriptome, defined as the complete set of messenger RNA (mRNA) transcripts, of these two cell lines relative to the wild-type parent?\n\nA. Cell Line A will exhibit a major disruption in the transcription of a small, specific set of genes, while Cell Line B will show a minor, widespread reduction across a large fraction of the transcriptome.\n\nB. Cell Line A will exhibit a broad, low-magnitude downregulation across a large percentage of its protein-coding genes, whereas Cell Line B will exhibit a significant change in expression limited to a discrete subset of genes.\n\nC. In both Cell Line A and Cell Line B, robust compensatory mechanisms will ensure that the global transcriptome remains virtually indistinguishable from a wild-type cell, as one functional allele is generally sufficient for normal function.\n\nD. Both Cell Line A and Cell Line B will exhibit a similar phenotype, characterized by a significant downregulation of a large fraction of the transcriptome, because all Mediator subunits are equally essential for its overall function.\n\nE. Cell Line A will be non-viable due to a complete collapse of transcription, while Cell Line B will be viable and show misregulation of only a few dozen genes.", "solution": "The key biological principle is that the Mediator Head and Middle modules constitute the core that broadly facilitates transcription by RNA Polymerase II at most promoters, whereas Tail subunits mediate interactions with specific transcription factors to regulate discrete gene programs. Therefore, dosage reduction of a core subunit is expected to influence many genes modestly by making a general step in transcription more limiting, while dosage reduction of a Tail subunit required only for a particular pathway should selectively alter the expression of genes in that pathway.\n\nFor Cell Line A, a heterozygous null for a Head module subunit indispensable for stable association of Mediator with RNA Polymerase II reduces the amount of functional Head subunit to approximately half. Because this Head subunit is generally required for stable Mediator–Pol II engagement across most protein-coding genes, partial reduction is predicted to make the assembly or stability of the preinitiation complex more limiting at many promoters. With one functional allele present, a complete collapse of transcription is not expected; instead, a broad, low-magnitude downregulation across a large fraction of the transcriptome is the most likely outcome, reflecting partial haploinsufficiency of a globally acting coactivator component.\n\nFor Cell Line B, a heterozygous null in a Tail subunit that is required exclusively for activation of genes responsive to a single non-essential nutrient-sensing pathway reduces the recruitment efficiency of Mediator specifically to targets of that pathway. Because this Tail subunit does not contribute generally to Mediator function outside that pathway, genes not regulated by that pathway should be largely unaffected under standard conditions. Consequently, the transcriptomic impact should be significant in magnitude but limited to a discrete subset of genes corresponding to that pathway.\n\nComparing these predictions to the options: Option B states that Cell Line A shows a broad, low-magnitude downregulation across many protein-coding genes, while Cell Line B shows a significant change limited to a discrete subset, which aligns with the reasoning above. Options A, C, D, and E are inconsistent: A reverses the expected breadth and magnitude; C assumes universal haplosufficiency, which is unlikely for a core coactivator; D incorrectly asserts equal essentiality across all subunits for global function; E incorrectly predicts non-viability and a complete collapse of transcription with only a single allele loss in the core subunit.", "answer": "$$\\boxed{B}$$", "id": "2342580"}, {"introduction": "Scientific models of molecular function, such as Mediator's role as a bridge, are built upon direct experimental evidence of physical interactions. This practice puts you in the lab coat of a molecular biologist tasked with verifying such an interaction. You will design a co-immunoprecipitation (Co-IP) experiment, a foundational technique used to demonstrate that two proteins, like a nuclear receptor and a Mediator subunit, physically associate within the cell. [@problem_id:2342530]", "problem": "A molecular biology research team is investigating the downstream signaling pathways of a newly discovered nuclear receptor, which they have named Glucocorticoid Receptor-Like Protein 1 (GRLP1). Their central hypothesis is that upon binding its specific synthetic ligand, Dexacortin, GRLP1 translocates to the nucleus and interacts with the MED1 subunit of the transcriptional coactivator Mediator complex to regulate gene expression.\n\nTo test this hypothesis, the team plans to use a co-immunoprecipitation (Co-IP) experiment on human cell cultures that endogenously express both GRLP1 and MED1. They have access to the following reagents: Dexacortin, a vehicle control (solvent for Dexacortin), a highly specific monoclonal antibody against GRLP1, a highly specific monoclonal antibody against MED1, and a non-specific control antibody (isotype-matched Immunoglobulin G, IgG).\n\nWhich of the following experimental designs is the most appropriate and comprehensive for testing the hypothesis that Dexacortin promotes a specific interaction between GRLP1 and MED1?\n\nA. Grow two separate cultures of cells. Treat one with Dexacortin and the other with the vehicle control. For each treatment condition, create two cell lysates. Perform immunoprecipitation on one lysate using the anti-GRLP1 antibody and on the other using the control IgG antibody. Analyze all four resulting eluates via Western blot using the anti-MED1 antibody.\n\nB. Treat a culture of cells with Dexacortin. Lyse the cells and perform immunoprecipitation using the anti-GRLP1 antibody. Analyze the resulting eluate via Western blot using the same anti-GRLP1 antibody.\n\nC. Grow two separate cultures of cells. Treat one with Dexacortin and the other with the vehicle control. Lyse the cells from each culture. Perform immunoprecipitation on both lysates using the anti-GRLP1 antibody. Analyze both resulting eluates via Western blot using the anti-MED1 antibody.\n\nD. Treat a culture of cells with Dexacortin. Lyse the cells and perform immunoprecipitation using the anti-GRLP1 antibody. Collect the supernatant (or flow-through) after the immunoprecipitation beads have been pelleted. Analyze this supernatant via Western blot using the anti-MED1 antibody.\n\nE. Grow two separate cultures of cells. Treat one with Dexacortin and the other with the vehicle control. Lyse the cells from each culture. Perform immunoprecipitation on both lysates using the anti-MED1 antibody. Analyze both resulting eluates via Western blot using a different control antibody, such as one for the housekeeping protein GAPDH.", "solution": "The hypothesis predicts that upon Dexacortin treatment, GRLP1 will interact specifically with MED1. The appropriate co-immunoprecipitation strategy must therefore:\n- Compare Dexacortin versus vehicle to determine ligand dependence.\n- Immunoprecipitate one partner (e.g., GRLP1) and detect the other partner (MED1) by Western blot to assess physical association.\n- Include an isotype-matched IgG immunoprecipitation control to assess non-specific binding to beads or antibody.\n- Keep all other conditions constant and analyze the bound (eluate) fraction, which contains the immunoprecipitated complexes.\n\nEvaluate the options against these requirements:\n- Option A: Includes Dexacortin and vehicle conditions. For each condition, performs an anti-GRLP1 IP and an isotype IgG IP, and probes all eluates with anti-MED1. This design tests ligand dependence (Dexacortin versus vehicle), demonstrates specificity (low or absent MED1 signal in IgG IPs), and directly detects the GRLP1–MED1 interaction in the bound fraction. It is appropriate and comprehensive among the choices.\n- Option B: IPs GRLP1 from Dexacortin-treated cells and blots with anti-GRLP1. This only confirms GRLP1 pull-down and reveals nothing about MED1 interaction or ligand dependence; it lacks vehicle and IgG controls.\n- Option C: Compares Dexacortin to vehicle, IPs GRLP1, and blots for MED1. This tests ligand dependence but lacks an IgG IP control to rule out non-specific binding, making it less comprehensive than Option A.\n- Option D: Analyzes the supernatant after IP for MED1. Because non-bound MED1 (not engaged with GRLP1) remains in the supernatant, this approach is indirect, insensitive, and confounded by abundant free MED1; it does not properly assess co-precipitation.\n- Option E: IPs MED1 but blots with an unrelated control antibody (e.g., GAPDH), which does not test for GRLP1–MED1 interaction and is therefore inappropriate.\n\nTherefore, the most appropriate and comprehensive design provided is Option A.", "answer": "$$\\boxed{A}$$", "id": "2342530"}]}